<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Endoscopic ultrasound in the staging of exocrine pancreatic cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Endoscopic ultrasound in the staging of exocrine pancreatic cancer</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Endoscopic ultrasound in the staging of exocrine pancreatic cancer</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Frank G Gress, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Douglas G Adler, MD, FACG, AGAF, FASGE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 31, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Exocrine pancreatic cancer is a common cause of cancer-related death in the United States and is second only to colorectal cancer as a cause of digestive cancer-related death [<a href="#rid1">1,2</a>]. Surgical resection offers the only potential cure, but because late presentation of the disease is common, only 10 to 15 percent of patients are candidates for surgical resection, and five-year survival rates remain limited. The main obstacles to potentially curative resection are the presence of distant metastases and/or invasion of nearby major vascular structures. (See  <a class="medical medical_review" href="/d/html/2480.html" rel="external">"Epidemiology and nonfamilial risk factors for exocrine pancreatic cancer"</a> and  <a class="medical medical_review" href="/d/html/2482.html" rel="external">"Overview of surgery in the treatment of exocrine pancreatic cancer and prognosis"</a>.)</p><p>This topic will review the role of endoscopic ultrasound in the staging of pancreatic cancer. The general approach to the diagnosis and staging of pancreatic cancer is discussed separately. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">TECHNIQUE</span><span class="headingEndMark"> — </span>The technical aspects of performing endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration or biopsy are presented elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2657.html" rel="external">"Endoscopic ultrasound: Examination of the upper gastrointestinal tract"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2656.html" rel="external">"Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2649.html" rel="external">"Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h1">STAGING</span><span class="headingEndMark"> — </span>Staging patients with pancreatic cancer includes determining the tumor-node-metastasis (TNM) stage  (<a class="graphic graphic_table graphicRef111135" href="/d/graphic/111135.html" rel="external">table 1</a>) as well as evaluating for vascular invasion [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer", section on 'Imaging studies'</a>.)</p><p>Multiple imaging modalities, including endoscopic ultrasound (EUS), are available for staging pancreatic cancer. EUS is effective for obtaining a tissue diagnosis, even if the tumor is poorly visualized by other imaging modalities. EUS is also used to evaluate patients with nonmetastatic disease that appears resectable on initial imaging (eg, computed tomography [CT] or magnetic resonance imaging [MRI]) [<a href="#rid4">4</a>]. </p><p class="headingAnchor" id="H4"><span class="h2">Goal of staging</span><span class="headingEndMark"> — </span>The goal of preoperative staging is to identify patients who might benefit from surgery while avoiding surgery in patients with locally advanced or metastatic disease. However, even with efforts to establish resectability preoperatively, many patients have unresectable tumors at surgery. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer"</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">TNM staging</span><span class="headingEndMark"> — </span>Pancreatic cancer is staged using the TNM system, which is outlined in the table  (<a class="graphic graphic_table graphicRef111135" href="/d/graphic/111135.html" rel="external">table 1</a>). EUS is useful for tumor and node staging, while alternative imaging modalities, such as CT or MRI, are required for metastasis staging. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer", section on 'Staging system and the staging workup'</a>.)</p><p>In general, EUS is more accurate than CT for T-staging of smaller tumors, whereas CT is more accurate than EUS for larger tumors [<a href="#rid5">5</a>]. EUS appears to be as accurate as multiphase, contrast-enhanced, multidetector CT (CE-MDCT) for N-staging [<a href="#rid6">6</a>]. </p><p class="headingAnchor" id="H6"><span class="h2">Evaluation of vascular invasion</span><span class="headingEndMark"> — </span>The presence or absence of vascular invasion is a major determinant of tumor resectability. However, vascular invasion does not automatically preclude resection since some vessels involved with the tumor can be resected and/or reconstructed. Thus, it is important to know whether vascular invasion is present and, if it is, to determine the specific anatomic location and the degree of vascular invasion.</p><p>Vascular invasion is probable if any of the following is present [<a href="#rid7">7</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Peripancreatic venous collaterals in an area of a mass that obliterates the normal anatomic location of a major portal confluence vessel</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tumor within the vessel lumen</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal vessel contour or irregular wall with loss of the vessel-parenchymal sonographic interface</p><p></p><p class="headingAnchor" id="H7"><span class="h1">ACCURACY OF EUS</span><span class="headingEndMark"> — </span>The reported accuracy of endoscopic ultrasound (EUS) for tumor-node-metastasis (TNM) staging and for determining vascular invasion is highly variable among studies [<a href="#rid8">8</a>]. Some studies show superiority to other imaging modalities, while other studies show equivalent or even inferior results for EUS [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer", section on 'Imaging studies'</a>.)</p><p>Several factors, such as the experience of the endosonographer and the endosonographer's knowledge of prior diagnostic imaging studies [<a href="#rid10">10</a>], may influence the staging accuracy of EUS. </p><p>The type of instrument used does not appear to influence staging accuracy. Both radial and linear array EUS instruments perform equally well, although the latter has the advantage of permitting fine needle aspiration (FNA) or fine needle biopsy (FNB) to be obtained [<a href="#rid11">11</a>]. (See <a class="local">'EUS with tissue sampling'</a> below.)</p><p class="headingAnchor" id="H8"><span class="h2">TNM stage</span><span class="headingEndMark"> — </span>The reported accuracy of EUS for T-staging is highly variable, ranging from 63 to 94 percent, with reported accuracies for N-staging ranging from 44 to 82 percent [<a href="#rid4">4,10,12-20</a>]. Comparing studies for T-staging is difficult because of changes in T-staging criteria over time. For example, two studies showed an accuracy of 63 and 67 percent for T-staging and 67 and 44 percent for N-staging [<a href="#rid19">19,20</a>]; however, these studies were based on an earlier version of the TNM staging classification. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer", section on 'Staging system and the staging workup'</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">Vascular invasion</span><span class="headingEndMark"> — </span>The reported sensitivity of EUS for detecting vascular invasion has varied widely, with estimates ranging from 50 to 100 percent [<a href="#rid21">21</a>]. A meta-analysis of 29 studies showed that EUS had high specificity (90 percent) but only moderate sensitivity (73 percent) for detecting vascular invasion [<a href="#rid21">21</a>].</p><p>EUS may not be as accurate in excluding vascular invasion in patients with small pancreatic tumors [<a href="#rid21">21</a>]. However, EUS is superior to other imaging modalities, such as CT and transabdominal ultrasound, for detecting vascular invasion for tumors that are smaller than 3 cm  (<a class="graphic graphic_diagnosticimage graphicRef141425" href="/d/graphic/141425.html" rel="external">image 1</a>) [<a href="#rid22">22,23</a>].</p><p>The accuracy of EUS also varies with the vessel being examined. The accuracy for detecting invasion into the superior mesenteric artery and vein is lower than that for detecting portal or splenic vein invasion [<a href="#rid10">10,24,25</a>].</p><p class="headingAnchor" id="H10"><span class="h1">COMPARISON OF EUS WITH OTHER IMAGING TECHNIQUES</span><span class="headingEndMark"> — </span>Studies have compared endoscopic ultrasound (EUS) with helical CT, multidetector CT (MDCT), and MRI for initial diagnosis and/or staging of pancreatic cancer [<a href="#rid9">9,26</a>]. However, direct comparison of the data can be difficult because of differences in inclusion criteria and reference standards. The imaging modalities chosen to stage patients with pancreatic cancer should take into account the studies' accuracy as well as local expertise.</p><p class="headingAnchor" id="H11"><span class="h2">Helical CT</span><span class="headingEndMark"> — </span>Multiple studies have compared the accuracy of EUS with helical CT for the evaluation of pancreatic cancer resectability [<a href="#rid6">6,19,20,27-33</a>]. However, the studies are heterogeneous, and most had methodologic flaws.</p><p>These limitations were highlighted in a systematic review that examined 11 studies with 678 patients [<a href="#rid6">6</a>]. Only three studies met all but one of the quality criteria. The most important and frequent study limitations were lack of a consecutive series of patients and biased patient selection for surgery that potentially affected validity. The older studies included in that review suggested that EUS was superior to CT for staging and determining vascular invasion. However, subsequent studies found that helical CT was more accurate than EUS for T-staging (73 versus 63 percent) and was equivalent for N-staging (62 to 63 percent versus 65 to 69 percent). EUS and CT were also equivalent with regard to detecting vascular invasion. Additional studies are needed before definitive conclusions can be made.</p><p class="headingAnchor" id="H12"><span class="h2">Contrast-enhanced multidetector CT</span><span class="headingEndMark"> — </span>CT scanners with multiple rows of detectors permit imaging of larger volumes of tissue while acquiring both arterial and venous phases in shorter periods of time [<a href="#rid19">19,34</a>]. Contrast-enhanced multidetector CT (CE-MDCT) has improved the evaluation of the main pancreatic duct and the detection of small tumors [<a href="#rid35">35</a>].</p><p>Only a few studies comparing EUS with multiphase CE-MDCT for detecting and staging pancreatic cancer are available. In a report of 80 patients who underwent EUS for pancreatic cancer, EUS was superior to CE-MDCT for tumor detection (sensitivity 98 versus 86 percent) and primary T-staging (accuracy 67 versus 41 percent), but similar for nodal staging (accuracy 44 versus 47 percent) [<a href="#rid20">20</a>]. Fifty-three patients underwent surgery and 25 were found to have resectable tumors. EUS and CE-MDCT correctly identified 88 and 92 percent of the resectable tumors. Of the 28 surgical patients with unresectable tumors, EUS and CE-MDCT correctly identified the tumors as being unresectable in 68 and 64 percent, respectively.</p><p class="headingAnchor" id="H14"><span class="h2">Magnetic resonance imaging</span><span class="headingEndMark"> — </span>Studies comparing EUS with MRI suggest that EUS may be more sensitive for detecting small tumors while providing complementary information regarding resectability [<a href="#rid16">16,19,36,37</a>].</p><p>A retrospective study focused on 63 patients with pancreatic cancer who underwent both examinations, using surgical results as the gold standard [<a href="#rid36">36</a>]. The tumor was resectable in 36 patients (57 percent). The sensitivities of EUS and MRI for determining resectability were 61 and 73 percent, respectively. EUS and MRI both predicted resectability in 18 patients, of whom 16 (89 percent) were found to be resectable at the time of surgery. Both studies predicted unresectability in 17 patients, of whom 13 (76 percent) were unresectable at the time of surgery.</p><p>In a prospective study of 48 patients who were staged with EUS and MRI prior to surgery, the correlation between EUS and MRI was fair (kappa 0.42), with agreement in the patient's staging seen in 74 percent [<a href="#rid38">38</a>]. EUS understaged 13 patients (27 percent), whereas MRI understaged 12 (25 percent). Only one patient was overstaged by EUS, and none were overstaged by MRI. MRI was more likely to report metastatic disease or arterial involvement.</p><p class="headingAnchor" id="H15"><span class="h2">PET scanning</span><span class="headingEndMark"> — </span>The role of positron emission tomography (PET) scanning for the staging of pancreatic cancer is discussed separately. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer", section on 'Positron emission tomography scanning'</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">EUS WITH TISSUE SAMPLING</span></p><p class="headingAnchor" id="H107023159"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Histologic confirmation is used establish a diagnosis of pancreatic cancer. Endoscopic ultrasound (EUS) with tissue sampling may facilitate the diagnosis and staging of pancreatic cancer. </p><p>EUS-guided fine needle biopsy (FNB) is used for sampling solid pancreatic lesions located in the pancreatic head, neck, body, and tail. EUS-FNB may be particularly helpful when EUS-guided fine needle aspiration (FNA) specimens have been nondiagnostic or additional tissue studies (eg, molecular testing) are needed [<a href="#rid39">39,40</a>]. The technique and accuracy of EUS-FNB for solid pancreatic lesions and other gastrointestinal lesions is discussed separately. (See  <a class="medical medical_review" href="/d/html/2649.html" rel="external">"Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"</a>.)</p><p>EUS with tissue sampling can be used to:</p><p class="bulletIndent1"><span class="glyph">●</span>Biopsy lesions that are too small to be characterized by computed tomography (CT) or magnetic resonance imaging (MRI) [<a href="#rid41">41</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Biopsy lesions that are too encased by surrounding vascular structures to permit safe percutaneous biopsy [<a href="#rid41">41</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Demonstrate malignant invasion of lymph nodes located in the celiac, para-aortic, retroduodenopancreatic, or superior mesenteric regions [<a href="#rid42">42</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Biopsy suspected small metastases in the left lobe of the liver [<a href="#rid43">43</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diagnose carcinomatosis through sampling of ascitic fluid [<a href="#rid44">44</a>]</p><p></p><p>Indications for EUS-FNA and EUS-FNB include [<a href="#rid4">4,27,45,46</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Ruling out other types of malignancy involving the pancreas that can mimic adenocarcinoma (eg, lymphoma and small cell carcinoma, metastatic disease, and gastrointestinal neuroendocrine tumors), as well as nonmalignant processes such as autoimmune or chronic pancreatitis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assisting with surgical planning (eg, a more limited resection may be possible in patients with neuroendocrine tumors).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Confirming the diagnosis prior to surgery. However, as noted in the next section, a negative result does not exclude malignancy.</p><p></p><p class="headingAnchor" id="H18"><span class="h2">Accuracy</span><span class="headingEndMark"> — </span>EUS-guided tissue sampling of solid pancreatic lesions is associated with high rates of technical success and diagnostic accuracy:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>EUS-FNB</strong> – Data suggest that diagnostic yield of EUS-FNB of solid pancreatic lesions is high (approximately 99 percent) [<a href="#rid39">39,40</a>]. The technical aspects, accuracy, and adverse events associated with EUS-FNB are discussed separately. (See  <a class="medical medical_review" href="/d/html/2649.html" rel="external">"Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>EUS-FNA</strong> – EUS-FNA is technically successful in 90 to 95 percent of procedures, with high sensitivity and specificity [<a href="#rid4">4</a>]. A meta-analysis of 15 studies with 1860 patients found that overall, the sensitivity of EUS-FNA for pancreatic cancer was 92 percent, and the specificity was 96 percent [<a href="#rid47">47</a>]. In a second meta-analysis that included 41 studies with 4766 patients, the pooled sensitivity of EUS-FNA for diagnosing the correct etiology for a solid pancreatic mass was 89 percent, with a specificity of 96 percent [<a href="#rid48">48</a>].</p><p></p><p class="bulletIndent1">The diagnostic accuracy appears to be lower in the setting of chronic pancreatitis (74 versus 91 percent in one report) [<a href="#rid49">49</a>], particularly in patients with obstructive jaundice [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1">The benefits of EUS-FNA are illustrated by a study of 559 patients undergoing EUS-FNA for evaluation of pancreatic masses [<a href="#rid51">51</a>]. In that study, when using strict cytologic criteria, the sensitivity for EUS-FNA diagnosing pancreatic adenocarcinoma was 77 percent, with a specificity of 99 percent. When patients with atypical or suspicious cytologies were reclassified as positive for malignancy, the sensitivity increased to 93 percent, without a change in the specificity.</p><p></p><p class="bulletIndent1">The accuracy of EUS-FNA can improve with additional FNA passes and onsite histologic interpretation [<a href="#rid52">52,53</a>]. In one report, the presence of a cytopathologist in attendance for all aspiration procedures was associated with a high degree of accuracy (95 percent) in diagnosing pancreatic cancer [<a href="#rid52">52</a>]. The absence of a cytopathologist during the EUS-FNA procedure required an average of at least five to six passes from the pancreatic mass to ensure adequate cellularity. In another study, there was a high yield from only two FNA passes when the samples were examined both by histology and cytology [<a href="#rid54">54</a>]. In that study, cytopathologists were not onsite during the procedure.</p><p></p><p class="bulletIndent1">The size of the needle used for FNA may also be important. In a meta-analysis of eight studies with 1292 patients, the sensitivity of FNA using a 25-gauge needle was higher than that for a 22-gauge needle (1 versus 0.85) with similar specificity (0.97 versus 0.93) [<a href="#rid55">55</a>].</p><p></p><p class="headingAnchor" id="H20"><span class="h2">Molecular genetic analysis</span><span class="headingEndMark"> — </span>The addition of molecular genetic analysis (eg, assay for K-ras or p53 gene mutations by reverse transcription-polymerase chain reaction or restriction length polymorphisms, promoter methylation of tumor suppressor genes, differential protein expression [proteomics]) to cytologic examination may improve the sensitivity of EUS with tissue sampling for diagnosing pancreatic cancer, especially in patients with small primary tumors [<a href="#rid56">56-63</a>].</p><p>In a study with 394 patients with pancreatic masses, K-ras mutations were present in 266 of 307 patients (87 percent) with pancreatic ductal adenocarcinoma and in 3 of 87 patients (3 percent) with non-pancreatic ductal adenocarcinoma [<a href="#rid62">62</a>]. When the results of the K-ras mutation analysis were combined with cytohistopathologic results, the sensitivity for detecting pancreatic ductal adenocarcinoma was 93 percent, and the specificity was 100 percent. However, others report a lower sensitivity (38 percent) of K-ras mutations for the detection of pancreatic cancer [<a href="#rid61">61</a>]. At present, molecular analysis of pancreatic aspirate is not a routine component of the diagnostic evaluation for pancreatic masses.</p><p class="headingAnchor" id="H3759311858"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111947.html" rel="external">"Society guideline links: Pancreatic cancer"</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Background</strong> – Staging patients with pancreatic cancer includes evaluating for tumor-node-metastasis (TNM) stage  (<a class="graphic graphic_table graphicRef111135" href="/d/graphic/111135.html" rel="external">table 1</a>) and determining if vascular invasion is present. (See  <a class="medical medical_review" href="/d/html/2501.html" rel="external">"Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer"</a>.)</p><p></p><p class="bulletIndent1">A variety of studies, including endoscopic ultrasound (EUS) and computed tomography, are available for preoperative diagnosis and staging of pancreatic cancer. The imaging modalities chosen should take into account the studies' accuracy as well as local expertise. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Staging</strong> – The goals of preoperative staging are to identify patients who might benefit from surgery and to avoid surgery in patients who have locally advanced or metastatic disease. The reported accuracy of EUS for TNM staging and for determining vascular invasion is highly variable. (See <a class="local">'Staging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tissue sampling</strong> – Histologic confirmation is used to establish a diagnosis of pancreatic cancer. EUS with tissue sampling may facilitate the diagnosis and staging of pancreatic cancer. (See <a class="local">'EUS with tissue sampling'</a> above.)</p><p></p><p class="bulletIndent1">EUS-guided fine needle biopsy (FNB) is used for sampling solid pancreatic lesions located in the pancreatic head, neck, body, and tail. EUS-FNB may be particularly helpful when EUS-guided fine needle aspiration (FNA) specimens have been nondiagnostic or additional tissue studies (eg, molecular testing) are needed. The technique and accuracy of EUS-FNB for solid pancreatic lesions and other gastrointestinal lesions is discussed separately. (See  <a class="medical medical_review" href="/d/html/2649.html" rel="external">"Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"</a>.)</p><p></p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 2006; 24:87.</a></li><li><a class="nounderline abstract_t">Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212.</a></li><li><a class="nounderline abstract_t">Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet 2020; 395:2008.</a></li><li><a class="nounderline abstract_t">Săftoiu A, Vilmann P. Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. J Clin Ultrasound 2009; 37:1.</a></li><li><a class="nounderline abstract_t">Varadarajulu S, Wallace MB. Applications of endoscopic ultrasonography in pancreatic cancer. Cancer Control 2004; 11:15.</a></li><li><a class="nounderline abstract_t">Dewitt J, Devereaux BM, Lehman GA, et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol 2006; 4:717.</a></li><li><a class="nounderline abstract_t">Snady H, Bruckner H, Siegel J, et al. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointest Endosc 1994; 40:326.</a></li><li><a class="nounderline abstract_t">Tamburrino D, Riviere D, Yaghoobi M, et al. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev 2016; 9:CD011515.</a></li><li><a class="nounderline abstract_t">Best LM, Rawji V, Pereira SP, et al. Imaging modalities for characterising focal pancreatic lesions. Cochrane Database Syst Rev 2017; 4:CD010213.</a></li><li><a class="nounderline abstract_t">Rösch T, Dittler HJ, Strobel K, et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc 2000; 52:469.</a></li><li><a class="nounderline abstract_t">Rösch T, Lorenz R, Braig C, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc 1991; 37:347.</a></li><li><a class="nounderline abstract_t">Gress FG, Hawes RH, Savides TJ, et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999; 50:786.</a></li><li><a class="nounderline abstract_t">Palazzo L, Roseau G, Gayet B, et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25:143.</a></li><li><a class="nounderline abstract_t">Grimm H, Maydeo A, Soehendra N. Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990; 4:869.</a></li><li><a class="nounderline abstract_t">Tio TL, Tytgat GN, Cikot RJ, et al. Ampullopancreatic carcinoma: preoperative TNM classification with endosonography. Radiology 1990; 175:455.</a></li><li><a class="nounderline abstract_t">Müller MF, Meyenberger C, Bertschinger P, et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190:745.</a></li><li><a class="nounderline abstract_t">Yasuda K, Mukai H, Nakajima M, Kawai K. Staging of pancreatic carcinoma by endoscopic ultrasonography. Endoscopy 1993; 25:151.</a></li><li><a class="nounderline abstract_t">Ahmad NA, Lewis JD, Ginsberg GG, et al. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000; 52:463.</a></li><li><a class="nounderline abstract_t">Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 2004; 99:492.</a></li><li><a class="nounderline abstract_t">DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004; 141:753.</a></li><li><a class="nounderline abstract_t">Puli SR, Singh S, Hagedorn CH, et al. Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review. Gastrointest Endosc 2007; 65:788.</a></li><li><a class="nounderline abstract_t">Yasuda K, Mukai H, Fujimoto S, et al. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc 1988; 34:1.</a></li><li><a class="nounderline abstract_t">Nakaizumi A, Uehara H, Iishi H, et al. Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer. Dig Dis Sci 1995; 40:696.</a></li><li><a class="nounderline abstract_t">Rösch T, Braig C, Gain T, et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102:188.</a></li><li><a class="nounderline abstract_t">Brugge WR, Lee MJ, Kelsey PB, et al. The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc 1996; 43:561.</a></li><li><a class="nounderline abstract_t">Du T, Bill KA, Ford J, et al. The diagnosis and staging of pancreatic cancer: A comparison of endoscopic ultrasound and computed tomography with pancreas protocol. Am J Surg 2018; 215:472.</a></li><li><a class="nounderline abstract_t">Hunt GC, Faigel DO. Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review. Gastrointest Endosc 2002; 55:232.</a></li><li><a class="nounderline abstract_t">Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000; 52:367.</a></li><li><a class="nounderline abstract_t">Midwinter MJ, Beveridge CJ, Wilsdon JB, et al. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999; 86:189.</a></li><li><a class="nounderline abstract_t">Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998; 170:1315.</a></li><li><a class="nounderline abstract_t">Tierney WM, Francis IR, Eckhauser F, et al. The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy. Gastrointest Endosc 2001; 53:182.</a></li><li><a class="nounderline abstract_t">Harewood GC, Wiersema MJ. Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses. Am J Gastroenterol 2002; 97:1386.</a></li><li><a class="nounderline abstract_t">Yang R, Lu M, Qian X, et al. Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review. J Cancer Res Clin Oncol 2014; 140:2077.</a></li><li><a class="nounderline abstract_t">Smith SL, Rajan PS. Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT. Clin Radiol 2004; 59:26.</a></li><li><a class="nounderline abstract_t">Fukushima H, Itoh S, Takada A, et al. Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma. Eur Radiol 2006; 16:1709.</a></li><li><a class="nounderline abstract_t">Ahmad NA, Lewis JD, Siegelman ES, et al. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am J Gastroenterol 2000; 95:1926.</a></li><li><a class="nounderline abstract_t">Cannon ME, Carpenter SL, Elta GH, et al. EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms. Gastrointest Endosc 1999; 50:27.</a></li><li><a class="nounderline abstract_t">Shami VM, Mahajan A, Loch MM, et al. Comparison between endoscopic ultrasound and magnetic resonance imaging for the staging of pancreatic cancer. Pancreas 2011; 40:567.</a></li><li><a class="nounderline abstract_t">Itonaga M, Yasukawa S, Fukutake N, et al. Comparison of 22-gauge standard and Franseen needles in EUS-guided tissue acquisition for diagnosing solid pancreatic lesions: a multicenter randomized controlled trial. Gastrointest Endosc 2022; 96:57.</a></li><li><a class="nounderline abstract_t">Temnykh LM, Rahal MA, Zia Z, Al-Haddad MA. An exclusive fine-needle biopsy approach to sampling solid lesions under EUS guidance: a prospective cohort study. Gastroenterol Rep (Oxf) 2020; 8:349.</a></li><li><a class="nounderline abstract_t">Gress F, Gottlieb K, Sherman S, Lehman G. Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer. Ann Intern Med 2001; 134:459.</a></li><li><a class="nounderline abstract_t">Williams DB, Sahai AV, Aabakken L, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999; 44:720.</a></li><li><a class="nounderline abstract_t">tenBerge J, Hoffman BJ, Hawes RH, et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc 2002; 55:859.</a></li><li><a class="nounderline abstract_t">Chang KJ, Albers CG, Nguyen P. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid. Am J Gastroenterol 1995; 90:148.</a></li><li><a class="nounderline abstract_t">Atiq M, Bhutani MS, Ross WA, et al. Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience. Pancreas 2013; 42:516.</a></li><li><a class="nounderline abstract_t">El Hajj II, LeBlanc JK, Sherman S, et al. Endoscopic ultrasound-guided biopsy of pancreatic metastases: a large single-center experience. Pancreas 2013; 42:524.</a></li><li><a class="nounderline abstract_t">Chen J, Yang R, Lu Y, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review. J Cancer Res Clin Oncol 2012; 138:1433.</a></li><li><a class="nounderline abstract_t">Puli SR, Bechtold ML, Buxbaum JL, Eloubeidi MA. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: A meta-analysis and systematic review. Pancreas 2013; 42:20.</a></li><li><a class="nounderline abstract_t">Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc 2005; 62:728.</a></li><li><a class="nounderline abstract_t">Krishna NB, Mehra M, Reddy AV, Agarwal B. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics. Gastrointest Endosc 2009; 70:70.</a></li><li><a class="nounderline abstract_t">Turner BG, Cizginer S, Agarwal D, et al. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 2010; 71:91.</a></li><li><a class="nounderline abstract_t">Erickson RA, Sayage-Rabie L, Beissner RS. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000; 51:184.</a></li><li><a class="nounderline abstract_t">Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, et al. Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol 2011; 106:1705.</a></li><li><a class="nounderline abstract_t">Möller K, Papanikolaou IS, Toermer T, et al. EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. Gastrointest Endosc 2009; 70:60.</a></li><li><a class="nounderline abstract_t">Madhoun MF, Wani SB, Rastogi A, et al. The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy 2013; 45:86.</a></li><li><a class="nounderline abstract_t">Urban T, Ricci S, Grange JD, et al. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 1993; 85:2008.</a></li><li><a class="nounderline abstract_t">Matsubayashi H, Canto M, Sato N, et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006; 66:1208.</a></li><li><a class="nounderline abstract_t">Teich N, Mossner J. Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors? Dig Dis 2004; 22:235.</a></li><li><a class="nounderline abstract_t">Chen R, Pan S, Cooke K, et al. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas 2007; 34:70.</a></li><li><a class="nounderline abstract_t">Tada M, Komatsu Y, Kawabe T, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002; 97:2263.</a></li><li><a class="nounderline abstract_t">Trümper L, Menges M, Daus H, et al. Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial. J Clin Oncol 2002; 20:4331.</a></li><li><a class="nounderline abstract_t">Ogura T, Yamao K, Sawaki A, et al. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses. Gastrointest Endosc 2012; 75:769.</a></li><li><a class="nounderline abstract_t">Fuccio L, Hassan C, Laterza L, et al. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. Gastrointest Endosc 2013; 78:596.</a></li></ol></div><div id="topicVersionRevision">Topic 5638 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16803606" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The epidemiology of pancreatic cancer in the United States: changes below the surface.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21685461" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32593337" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18932265" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14749619" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Applications of endoscopic ultrasonography in pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16675307" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8056236" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27631326" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28415140" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Imaging modalities for characterising focal pancreatic lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11023562" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2070987" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Endoscopic ultrasound in pancreatic tumor diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10570337" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8491130" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2078789" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2183284" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Ampullopancreatic carcinoma: preoperative TNM classification with endosonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8115622" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8491131" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Staging of pancreatic carcinoma by endoscopic ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11023561" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : EUS in preoperative staging of pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15056091" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15545675" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17350008" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Diagnostic accuracy of EUS for vascular invasion in pancreatic and periampullary cancers: a meta-analysis and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3280392" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The diagnosis of pancreatic cancer by endoscopic ultrasonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7895567" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1727753" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8781933" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29174773" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The diagnosis and staging of pancreatic cancer: A comparison of endoscopic ultrasound and computed tomography with pancreas protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11818928" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10968852" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10100785" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9574609" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11174289" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12094855" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Endosonography-guided fine needle aspiration biopsy in the evaluation of pancreatic masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24916170" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14697372" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16550353" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Diagnostic value of curved multiplanar reformatted images in multislice CT for the detection of resectable pancreatic ductal adenocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10950037" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10385718" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : EUS compared with CT, magnetic resonance imaging, and angiography and the influence of biliary stenting on staging accuracy of ampullary neoplasms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21499211" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Comparison between endoscopic ultrasound and magnetic resonance imaging for the staging of pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35151711" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Comparison of 22-gauge standard and Franseen needles in EUS-guided tissue acquisition for diagnosing solid pancreatic lesions: a multicenter randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33163189" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : An exclusive fine-needle biopsy approach to sampling solid lesions under EUS guidance: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11255521" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Endoscopic ultrasonography-guided fine-needle aspiration biopsy of suspected pancreatic cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10205212" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12024141" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7801920" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23211369" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23146924" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Endoscopic ultrasound-guided biopsy of pancreatic metastases: a large single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22752601" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23254913" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: A meta-analysis and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16246688" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19249774" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19846087" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10650262" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21483464" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Influence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19394012" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23307148" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7902444" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16424060" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15753605" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Molecular analysis of pancreatic juice: a helpful tool to differentiate benign and malignant pancreatic tumors?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17198186" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12358243" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12409332" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22284089" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23660563" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
